Fifty-eight percent of medications in development today are small molecule drugs, and many of them are earmarked for oncology drug products. Worldwide, the market demand for oncology products is attributed to regional and environmental factors. Your ability to navigate a complex regulatory environment, handle high-potency materials, overcome bioavailability challenges, and optimize the supply chain is vital to the success of your oncology drug product. Thermo Fisher Scientific provides a range of small molecule solutions that you can leverage to address your oncology program’s unique needs and challenges, while being backed by a global network of technical, quality, and customer engagement teams and industry experts.
In this brochure, learn how to:
- Navigate a complex regulatory environment
- Handle high-potency materials
- Address bioavailability challenges
- Optimize the supply chain